Digital Media briefs

Share this article:
The AMA adopted a new policy for physician use of using social media. The guidelines, one of the first such codes issued by a major American physician organization, encourage doctors to: refrain from posting identifiable patient information online; when interacting with patients, maintain appropriate boundaries of the patient-physician relationship; and flag “unprofessional” content posted by colleagues and report it to authorities.

WebMD founder Jeff Arnold has launched Sharecare.com, a website that aims, he said, “to become a trusted resource for accurate, multi-perspective and high quality answers to questions of health.” The site, backed by Discovery Communications and Sony Pictures Television, has lined up Dr. Mehmet Oz (above), of The Dr. Oz Show, to anchor its roster of celebrity contributors.

The AARP and Consumer Reports Health launched an “online drug comparison tool” that uses Consumers Union data to compare drug safety, effectiveness, convenience and price, plus tips on how to talk to their doctor about the drugs. The AARP Drug Savings Tool (drugsavings.aarp.org) covers about 500 drugs in 26 classes and gives “best buy” recommendations.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?